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          ASSOCIATED W工TH HYPERCALCEMIA
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                （Director： Prof． K． Koshiba， M． D．）
    Four cases of rnalignant urological tumors associated with hypercalcemia were presented．
    The first case was a 48－year－old man who was diagriosed as bladder tumor with bilateral lung and
right 5th rib metastases． She had been treated with irradiation （Liniac： 6000 rads） and anti－cancer
chemotherapy （Neocartinostatin： total 20，000 units）． From the 2eth hospital day， serum Ca level
increased progressively which was treated with pig一 and eel－calcitonin and predonine． On the 43th
’hospital day，’ serum Ca， ion－Ca， P and alka｝ine phosphatase were 17．2 mg／dl， 9．7 mg／dl， 4．6 mg／dl
and 21 units respectively but parathyroid hormone was O．13 ng／ml． He died on the 45th hospital day．
    The second case was a 62－year－old man who had been diagnosed as penile cancer 2 years ago
and had treatment with irradiation （Liniac： 6，000 rads） and anticancer chemotherapy （Bleomycin：
total 300 mg） followed by partial amputation with bilateral inguinal and pelvic lymph node dissection．
At the time of admission to our clinic， serum Ca level was 13．3 mg／dl and bone scan did not show
any hyperaccumulative lesien． Serum PTH and PGE were O．42 ng／ml and 120 pgfml． He was
treated with eel－calcitonin， predonine and indomethacin but died on th．e 18th hospital day． ln autopsy，
metastatic lesion was seen in the left lung but the parathyroid and bone were free of abnormality．
    The third case was a 63－year－old womah who was diagnosied as bladder tumor with left supra－
clavicUlar lymph n6de and right femur metastases． She W’as treated with irradiation （Liniac： 6，000
rads）， total cys’tecto皿y a血d．bilateral ureterocutaneostomy．．From the 14th hospital day， serum Ca
Tevel incrcased pyogr¢ssively． ＄he w．as treated with eel－calcitonin， predonine and indomethacin and
on． the 34th hopptal day， sigrum Ca， PTH and PGE Were 15．2 mg／dl， O．10 ng／ml and 20 pg／ml respect－
ively． She died on the 50th hospital day．
    The fourth case was a 73－year－old man who had right nephroureterectomy under a’diagnosis
of right renal pelvic tumor 2 years ago． At the second time of admissien to our clinic， multiple liver
metastases was shown in liver scan and bone scan revealed hyperaccumulation in the third lumbar
vertebra and the right 5，6th ribs． On the secgnd hospital day， serum Ca was 10．7 mg／dl． On the
17th hospital day， serum Ca， PTH， PGE， urine and serum cyclic－AMP were 13．7 mg／dl， O． I O ng／ml，
274pg／ml， 3．60 mcm／24h and 56．5 pmol／ml respectively． ． He was treated with eel－calcitonip and
predonine but died on the 25th hospital day．































mm3， Hb l 2．79／dl，西小階数30×104／mm3
赤沈値；1時間76mm
血液化学；総蛋自量6．49／dl， BUN I7 mg／dl， Cr O．9
mg／dl， Na 138 mEq／L， K 3．8 mEq／L， Cl 9．5 rnEq／L，









































mm3 Hb 7．49／dl，血小板数20．4 × 104／mm3
赤沈値；1時間118皿m
血液化学；総蛋白量7．79／dl， BuN 97 mg／dl， cr 3・9
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Fig． 2． Case Clinical course．
血液一般；赤血球数409×104／mm3，白血球数5000／
mm3， Hb l 3．89／dl，血小板数17，1×104／mm3
赤沈値；1時間42mm
血液化学；総蛋臼量6．89／d1， BuN g mg／dl， cr o．5
mg／dl，総ビリルビン1．5 mg／dl， GOT l45 u， GPT
134r u， A正p 40 u， Na 141 mEq／L， K 3，3 mEq／L， C1






























rnm3， Hb 11．1 g／dl
赤沈値；1時聞32mm
血液化学；総蛋白量6．89／dl， BUN 25 mg／d1， Cr l．1
mg／dl， T． Bil 2．1mg／dl， GOT 35 u， GPT 1．9u，
LDH 469 u， Na 137 mEqfL， K 3．4 mEq／L， Cl 103
mEq／L， Ca IO．1mg／dl， P 2・9 mg／dl， HB抗原（一），







高値を示したが血中PTHは0．10 ng／mI， PGE 274
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Table 1． Causes of hypercalcemia associated
     with neoplastic disease．
  1） Wldespread destruction of
    bone by metastases
  2｝ Tumor production ot substances
    with hypercaicernia activity
    a｝ Parathyroid hormone（PTH）
    b） Prostaglandin
    c ） Vltamin D like substance
    d ） Osteoclast activating tactor
  5） Sarcoidosis， rnvMPIe myeloma，
    leukemia， pheochromocytornd etc．
： pmot／mi 5 10 15 20
Fig． 4． Case 4， Clinical course．
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Table 2． Max laboratoly level and bone metastases in 4 cases．
   Age8       DiagnosisCase   sex
Serum Ca Serum P PTH PGE Bone
｛rng／dl） ｛mg／dl） （ng／m l） （pg／rn l） metastases
M．Y． 48，M Bladder tumor i 7，2
工．Y． 62 M Penis cqncer    ’ 15，5























Normal range ： Serurn Ca 8，5一”IOIsmg／dl， Serum P 2．7t－4．5mg／dl，




















































Table 3． Treatment of hypercalcemic malignant
     tumors．
 ［ ） Replace flulds wlth saline
 2） Diuretics ｛furosemide 40r80mg）
 5 ｝ Correction ot electrolytes
 4） Decrease the calcium intakeC〈400mg／day）
 5） Exciude vitamine D frorn the diet
 6） Avoid immobilization
 7） Orai phosphate（200mg／day｝ to decrease the
  resorption ot calcium trom the gut
 8） Steroids（30一一40mg／day｝ that have an
  anti 一一 vitamin D effect that may reduce
  gastrointestinal ana bone absorption
  ot calcium
 9） Actlnomycin D and mithramycin ｛25Ng／kg）
   tor the hypercalcemic eftect
lO）工ndomethacin｛［00～200mg／doy｝or
  aspirin（2，4gfday）for a pfostaglandin
  synthesis inhibltor
口｝Cdcitonin（sGlmon，pig，eeD
i2） Specific chemotherapy and radiotherapy
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